A detailed history of Reuter James Wealth Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Reuter James Wealth Management, LLC holds 2,318 shares of AMGN stock, worth $682,720. This represents 0.14% of its overall portfolio holdings.

Number of Shares
2,318
Previous 3,064 24.35%
Holding current value
$682,720
Previous $957,000 22.05%
% of portfolio
0.14%
Previous 0.72%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$309.38 - $337.38 $230,797 - $251,685
-746 Reduced 24.35%
2,318 $746,000
Q2 2024

Aug 01, 2024

BUY
$262.75 - $319.31 $79,876 - $97,070
304 Added 11.01%
3,064 $957,000
Q1 2024

May 06, 2024

SELL
$268.87 - $324.56 $54,042 - $65,236
-201 Reduced 6.79%
2,760 $784,000
Q4 2023

Apr 08, 2024

SELL
$255.7 - $288.46 $408,352 - $460,670
-1,597 Reduced 35.04%
2,961 $852,000
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $42,636 - $52,934
195 Added 4.47%
4,558 $1.23 Million
Q2 2023

Aug 07, 2023

BUY
$214.27 - $253.37 $303,406 - $358,771
1,416 Added 48.05%
4,363 $968,000
Q1 2023

May 10, 2023

BUY
$225.79 - $275.2 $193,727 - $236,121
858 Added 41.07%
2,947 $712,000
Q4 2022

Feb 06, 2023

SELL
$229.03 - $291.01 $461,266 - $586,094
-2,014 Reduced 49.09%
2,089 $548,000
Q3 2022

Nov 04, 2022

BUY
$224.46 - $253.15 $166,100 - $187,331
740 Added 22.0%
4,103 $925,000
Q2 2022

Aug 09, 2022

SELL
$230.71 - $256.74 $3,229 - $3,594
-14 Reduced 0.41%
3,363 $818,000
Q1 2022

Apr 14, 2022

SELL
$219.27 - $242.57 $4,823 - $5,336
-22 Reduced 0.65%
3,377 $817,000
Q4 2021

Jan 25, 2022

BUY
$198.88 - $227.6 $675,993 - $773,612
3,399 New
3,399 $765,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Reuter James Wealth Management, LLC Portfolio

Follow Reuter James Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Reuter James Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Reuter James Wealth Management, LLC with notifications on news.